Intraoperative lymph node staging in bronchogenic carcinoma. Consensus report;Estadificaciön ganglionar intraoperatoria en la cirugía del carcinoma broncogénico. Documento de consenso

Archivos de Bronconeumologia

Volumn 37, Issue 11, 2001, Pages 495-503

  Rami Porta, R ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Bronchogenic carcinoma; Mediastinal lymph nodes; Nodal staging; Systematic nodal dissection

Indexed keywords

BIOPSY; CANCER STAGING; CONFERENCE PAPER; HUMAN; LUNG CARCINOMA; LUNG TUMOR; LYMPH NODE METASTASIS; PATHOLOGY; PEROPERATIVE CARE;

BIOPSY; CARCINOMA, BRONCHOGENIC; ENGLISH ABSTRACT; HUMAN; INTRAOPERATIVE CARE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM STAGING;

EID: 0347698483     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(01)75129-0     Document Type: Article

References (58)

1. Thomas PA. Role of mediastinal staging of lung cancer. Chet 1994; 106: 5331-5333.
2. Grupo de trabajo de la SEPAR. Normativa actualizada (1998) sobre diagnóstico y estadificación del carcinoma broncogénico. Arch Bronconeumol 1998; 34: 437-452.
3. Holmes EC. General principles of surgery quality control. Chest 1994; 106: 5334-5336.
4. Izbicki JR, Passlick B, Pantel K, Pichlmeier U, Hosch SB, Karg O et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectale non-small cell lung cancer. Ann Surg 1998; 227: 138-144.
5. Keller SM, Adak S, Wagner H, Johnson DH, por el Eastern Cooperative Oncology Group. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Ann Thorac Surg 2000; 70: 358-366.
6. Grupo Cooperativo de Carcinoma Broncogénico de SEPAR (GCCB-S). Cirugía del carcinoma broncogénico en España. Estudio descriptivo. Arch Bronconeumol 1995; 31: 303-309.
7. Duque JL, Ramos G, Castrodeza J, Castanedo M, García-Yuste et al, y el Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica. Early complications in surgical treatment of lung cancer: a prospective, multicenter. Ann Thorac Surg 1997; 63: 944-950.
8. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-1717.
9. Rami-Porta R, Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica. Reflections on the Revisions in the International System for Staging Lung Cancer. Chest 1998; 113: 1728-1729.
10. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery. Survival of lung cancer according to the 1997 pathological TNM classification in a multicenter experience in Spain. Lung Cancer 2000; 29 (Supl 1): 133-134.
11. American Thoracic Society. Clinical staging of primary lung cancer. Am Rev Respir Dis 1983; 127: 659-664.
12. López Encuentra A, León González C, López Mejías J et al. Grupo de Trabajo SEPAR. Normativa sobre nomenclatura y clasificación del carcinoma broncogénico. Barcelona: Doyma, S.A., 1986.
13. Grupo Cooperativo de Carcinoma Broncogénico de SEPAR (GCCB-S). Control de calidad en un registro multiinstitucional de carcinoma broncogénico. Arch Bronconeumol 1996; 32 (Supl 2): 70.
14. a ed.). Nueva York: Wiley-Liss, 1997; 95.
15. Goldstraw P. Report on the International workshop on intrathoracic staging. London, October 1996; Lung Cancer 1997; 18: 107-111.
16. Riquet M, Manac'h D, Le Pimpec-Barthes F, Dujon A, Chehab A. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg 1999; 67: 1572-1576.
17. Van Velzen E, Snijder RJ, Brutel de la Rivière A, Elbers HJJ, Van der Bosch JMM. Thype of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Chest 1996; 110: 1469-1473.
18. The Lung Cancer Study Group (Thomas PA, Piantadosi S, Mountain CF). Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? J Thorac Cardiovasc Surg 1988; 95: 883-887.
19. Mountain CF, Lukeman JM, Hammar SP, Chamberlain DW, Coulson WF, Page DL et al, y el Lung Cancer Study Group Pathology Committee. Lung cancer classification: the relationship of disease extent and cell type to survical in a clinical trials population. J Surg Oncol 1987; 35: 147-156.
20. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery. Clinical tumor size and prognosis in lung cancer. Eur Respir J 1999; 14: 812-816.
21. Hata E, Miyamoto H, Kohijama R, Tanaka M, Sakao Y, Harada R. Resection of N2/N3 mediastinal disease: En: Motta G, editor. Lung cancer, frontiers in science and treatment. Génova: Gráfica LP, 1994; 431-444.
22. a ed.). Baltimore: Williams & Wilkins, 1995; 469-480.
23. Watanabe Y, Shimizu J, Tsubota M, Iwa T. Mediastinal spread of metastasic lymph nodes in bronchogenic carcinoma. Mediastinal nodal metastases in lung cancer. Chest 1990; 97: 1059-1065.
24. Watanabe Y, Hayashi Y, Shimizu J, Oda M, Iwa T. Mediastinal nodal involvement and the prognosis on non-small cell lung cancer. Chest 1991; 100: 422-428.
25. Watanabe Y, Shimizu J, Oda M, Hayashi Y, Watanabe S, Tatsuzawa Y, et al. Aggressive surgical intervention in N2 non-small cell cancer of the lung. Ann Thorac Surg 1991; 51: 253-261.
26. Shitara Y, Tanaka S, Yajima Y, Mogi A, Nouchi T, Endoh H et al. Evaluation of extended lymph node dissection by right side VATS. Lung Cancer 2000; 29 (Supl 1): 152.
27. Kawahara K, Shiraishi T, Iwasaki A, Okabayashi K, Yoneda S, Shirakusa T. Minimally invasive surgery for primary lung cancer. Lung Cancer 2000; 29 (Supl 2): 112.
28. Vansteenkiste JF, Den Leyn PR, Deneffe GJ et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Ann Thorac Surg 1997; 63: 1441-1450.
29. Yano T, Fukuyama Y, Yokoyama H et al. Long-term survivors with pN2 non-small cell lung cancer after a complete resection with a systematic mediastinal node dissection. Eur J Cardiothorac Surg 1998; 14: 152-155.
30. Sagawa M, Sakurada A, Fujimura S et al. Five-year survivors with resected pN2 non-small cell lung carcinoma. Cancer 1999; 85: 864-868.
31. Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Matsuoka H. Prognosis of completely rese3cted pN2 non-small cell lung carcinomas: what is the significant node that affects survival? J Thorac Cardiovasc Surg 1999; 118: 270-275.
32. Izbicki JR, Passlick B, Karg O, Bloechle C, Pantel K, Knoefel W, Thetter O. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 1995; 59: 209-214.
33. De Leyn P, Schoonooghe P, Deneffe G, Van Raemdonck D, Coosemans W, Vansteenkiste J et al. Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease). Eur J Cardiothorac Surg 1996; 10: 649-655.
34. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Shimosato Y, Naruke T. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg 1996; 111: 1125-1234.
35. Graham ANJ, Chan KJM, Pastorino U, Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cell lung cancer. J Thorac Cardiovasc Surg 1999; 117: 246-251.
36. Koike T, Terashima M, Takizawa T, Kurita Y, Yokoyama A. Clinical analysis of small-sized peripheral lung cancer. J Thorac Cardiovasc Surg 1998; 115: 1015-1020.
37. Asamura H, Hakayama H, Kondo H, Tsuchiya R, Naruke T. Lobe-specific extent of systematic node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg 1999; 117: 1102-1111.
38. Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H. Lymph node sampling in lung cancer: how should it be done? Eur J Cardiothorac Surg 1999; 16 (Supl 1): 17-24.
39. Martini N, Flehinger GJ, Zaman MG, Beattie EJ Jr. Prospective study of 445 lung carcinomas with mediastinal lymph node metastases. J Thorac Cardiovasc Surg 180; 80: 390-397.
40. Martini N, Flehinger BJ, Zaman MB, Beattie FJ Jr. Results of surgical treatment in N2 lung cancer. World J Surg 1981; 5: 675-679.
41. Martini N, Flehinger BJ, Zaman MB, Beattie EJ Jr. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node mestastases. Ann Surg 1983; 198: 386-397.
42. Martini N, Flehinger BJ, Bains MS, McCormack P. Alternate approaches to the management of mediastinal adenopathy. En Delarue NC, Eschapasse H, editores. Lung Cancer. International trends in general thoracic surgery (Volumen 1). Filadelfia: WB Saunders Company, 1985; 108-120.
43. Martini N. Mediastinal lymph node dissection for lung cancer. Chest Surg Clin North Am 1995; 5: 189-203.
44. Naruke T, Suemasu K, Ishikawa S. Surgical treatment for lung cancer with metastasis to mediastinal lymph nodes. J Thorac Cardiovasc Surg 1976; 71: 279-285.
45. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978; 76: 832-839.
46. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96: 440-447.
47. Naruke T. Mediastinal lymph node dissection. En: Pearson FG, Deslauriers J, Ginsberg RJ, Hiebert CA, McKneally MF, Urschel HC, editores. Thoracic surgery. Nueva York: Churchill Livingstone, 1995; 909-917.
48. Lee JD, Ginserg RJ. Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed ant mediastinoscopy. Ann Throac Surg 1996; 62: 338-341.
49. Little AG, DeHoyos A, Kirgan DM, Arcomano TR, Murray KD. Intraoperative lymphatic mapping for non-small cell lung cancer: The sentinel node technique. J Thorac Cardiovasc Surg 1999; 117: 220-224
50. Sugi K, Kaneda Y, Esato K. Identification of the sentinel lymph node by staining in lung cancer patients. Lung Cancer 2000; 29 (Supl 1): 139.
51. Liptay MJ, Masters GA, Winchester DJ, Edelman BL, Garrido BJ, Hirschtritt TR et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg 2000; 70: 384-390.
52. Tiffet O, Davies G, Genc O, Nicholson AG, Ladas G, Underwood R et al. Preoperative detection of the sentinel lymph node in non-small cell lung cancer with radioisotopic and blue dye technique. Lung Cancer 2000; 29 (Supl 1): 138-139.
53. Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of resected primary lung carcinomas. Am J Clin Pathol 1995; 104: 371-374.
54. Nash G, Hutter R, Henson DE. Practice protocol for the examination of specimens from patients with lung cancer. Arch Pathol Lab Med 1995; 119: 695-700.
55. a ed.). St. Louis: Mosby, 1996; 8.
56. Watanabe S, Ladas G, Goldstraw P. Inter-observed variability in sistematic nodal dissection: a comparison of European and Japanese nodal designation. Lung Cancer 2000; 29 (Supl 1): 132-133.
57. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111: 1718-1723.
58. a ed.). Tokio: Kanehara & Co., Ltd., 2000; 6-14 y 22-31.